Skip to main content
Log in

Histologisches Spektrum des malignen Melanoms

Histological spectrum of malignant melanoma

  • Schwerpunkt
  • Published:
Der Pathologe Aims and scope Submit manuscript

Zusammenfassung

Die Gruppe der melanozytären Tumoren gehört zu den diagnostisch problematischsten Gebieten in der Dermatologie und Histopathologie. Das Melanom ist ein bösartiger melanozytärer Tumor, dessen Metastasen- und Mortalitätsrisiko hauptsächlich von der Invasionstiefe und Tumordicke bestimmt wird. Eine frühzeitige Erkennung und die korrekte Diagnose sind daher Voraussetzungen für eine erfolgreiche Behandlung. Erschwert wird die Diagnose des Melanoms jedoch durch das breite morphologische Spektrum. Historisch wurde das Melanom in das superfiziell spreitende, das noduläre, die Lentigo maligna und das akral lentiginöse Melanom unterteilt. Über die Jahre sind dieser Unterteilung noch viele andere Melanomvarianten hinzugefügt worden. Neuere Erkenntnisse zeigen, dass einige dieser Untergruppen auch spezifische genetische Veränderungen, klinische Präsentationen, Prognosen und Behandlungen sowie Differenzialdiagnosen aufweisen. Vier dieser klinisch bedeutenden Varianten, nämlich das desmoplastische Melanom, das nävoide Melanom, der maligne blaue Nävus und das pigmentsynthetisierende Melanom, werden in diesem Artikel besprochen.

Abstract

The diagnosis of melanocytic tumors is one of the most problematic areas in dermatology and diagnostic pathology. Melanoma is a malignant melanocytic tumor and the risk for metastasis and associated mortality is mainly dependent on tumor thickness and depth of invasion. Early recognition and correct diagnosis is therefore important for successful and effective treatment. The correct diagnosis of melanoma is, however, challenging due to the wide morphological spectrum. Historically, the disease was subdivided into superficial spreading, nodular, lentigo maligna and acral lentiginous melanoma but many more subtypes have subsequently been added. Some of these melanoma variants also show differences relating to the genetic background, clinical presentation, prognosis and treatment and may be associated with a specific differential diagnosis. In this article four of these melanoma variants, desmoplastic melanoma, nevoid melanoma, malignant blue nevus and pigment synthesizing melanoma will be discussed in more detail.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Antony FC, Sanclemente G, Shaikh H et al (2006) Pigment synthesizing melanoma (so-called animal type melanoma): a clinicopathological study of 14 cases of a poorly known distinctive variant of melanoma. Histopathology 48:754–762

    Article  CAS  PubMed  Google Scholar 

  2. Barnhill RL, Argenyi Z, Berwick M et al (2008) Atypical cellular blue nevi (cellular blue nevi with atypical features): lack of consensus for diagnosis and distinction from cellular blue nevi and malignant melanoma („malignant blue nevus“). Am J Surg Pathol 32:36–44

    Article  PubMed  Google Scholar 

  3. Blessing K, Evans AT, Al-Nafussi A (1993) Verrucous naevoid and keratotic malignant melanoma: a clinico-pathological study of 20 cases. Histopathology 23:453–458

    Article  CAS  PubMed  Google Scholar 

  4. Busam KJ, Mujumdar U, Hummer AJ et al (2004) Cutaneous desmoplastic melanoma: reappraisal of morphologic heterogeneity and prognostic factors. Am J Surg Pathol 28:1518–1525

    Article  PubMed  Google Scholar 

  5. Busam KJ, Zhao H, Coit DG et al (2005) Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling. J Invest Dermatol 124:412–418

    Article  CAS  PubMed  Google Scholar 

  6. Chen LL, Jaimes N, Barker CA et al (2013) Desmoplastic melanoma: a review. J Am Acad Dermatol 68:825–833

    Article  PubMed  Google Scholar 

  7. Clark WH Jr, From L, Bernardino EA et al (1969) The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res 29:705–727

    PubMed  Google Scholar 

  8. Conley J, Lattes R, Orr W (1971) Desmoplastic malignant melanoma (a rare variant of spindle cell melanoma). Cancer 28:914–936

    Article  CAS  PubMed  Google Scholar 

  9. Gerami P, Beilfuss B, Haghighat Z et al (2011) Fluorescence in situ hybridization as an ancillary method for the distinction of desmoplastic melanomas from sclerosing melanocytic nevi. J Cutan Pathol 38:329–334

    Article  PubMed  Google Scholar 

  10. Gerami P, Wass A, Mafee M et al (2009) Fluorescence in situ hybridization for distinguishing nevoid melanomas from mitotically active nevi. Am J Surg Pathol 33:1783–1788

    Article  PubMed  Google Scholar 

  11. Granter SR, Mckee PH, Calonje E et al (2001) Melanoma associated with blue nevus and melanoma mimicking cellular blue nevus: a clinicopathologic study of 10 cases on the spectrum of so-called ‚malignant blue nevus’. Am J Surg Pathol 25:316–323

    Article  CAS  PubMed  Google Scholar 

  12. Ludgate MW, Fullen DR, Lee J et al (2010) Animal-type melanoma: a clinical and histopathological study of 22 cases from a single institution. Br J Dermatol 162:129–136

    Article  CAS  PubMed  Google Scholar 

  13. Mandal RV, Murali R, Lundquist KF et al (2009) Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am J Surg Pathol 33:1778–1782

    Article  PubMed  Google Scholar 

  14. Martin RC, Murali R, Scolyer RA et al (2009) So-called „malignant blue nevus“: a clinicopathologic study of 23 patients. Cancer 115:2949–2955

    Article  PubMed  Google Scholar 

  15. Miller DD, Emley A, Yang S et al (2012) Mixed versus pure variants of desmoplastic melanoma: a genetic and immunohistochemical appraisal. Mod Pathol 25:505–515

    Article  CAS  PubMed  Google Scholar 

  16. Murali R, Shaw HM, Lai K et al (2010) Prognostic factors in cutaneous desmoplastic melanoma: a study of 252 patients. Cancer 116:4130–4138

    Article  PubMed  Google Scholar 

  17. Schmoeckel C, Castro CE, Braun-Falco O (1985) Nevoid malignant melanoma. Arch Dermatol Res 277:362–369

    Article  CAS  PubMed  Google Scholar 

  18. Zembowicz A, Carney JA, Mihm MC (2004) Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol 28:31–40

    Article  PubMed  Google Scholar 

  19. Zembowicz A, Knoepp SM, Bei T et al (2007) Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol 31:1764–1775

    Article  PubMed  Google Scholar 

  20. Zembowicz A, McCusker M, Chiarelli C et al (2001) Morphological analysis of nevoid melanoma: a study of 20 cases with a review of the literature. Am J Dermatopathol 23:167–175

    Article  CAS  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. T. Brenn gibt an, dass kein Interessenkonflikt besteht Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to T. Brenn MD, PhD, FRCPath.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Brenn, T. Histologisches Spektrum des malignen Melanoms. Pathologe 36, 53–61 (2015). https://doi.org/10.1007/s00292-014-2001-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00292-014-2001-4

Schlüsselwörter

Keywords

Navigation